ClinicalTrials.gov
ClinicalTrials.gov Menu

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01480050
Recruitment Status : Completed
First Posted : November 28, 2011
Last Update Posted : October 14, 2016
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Cavion, Inc.
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2015
  Study Completion Date : No date given